Skip to content

IAS: WHO clinical staging excluding many without symptoms from HIV treatment, despite need

IAS: Studies in Uganda show generic fixed-dose combinations safe and effective in children with HIV

Tipranavir moves closer to approval in Europe

IAS: High risk of death for South Africans in first six months of ART, isoniazid may reduce risk

IAS: Columbia University is coordinating treatment scale at multiple sites in several sub-Saharan African countries

IAS: 3TC infant prophylaxis during breast-feeding reduces HIV infection rate at six months

IAS: Study in Côte d’Ivoire describes factors associated with survival in older children with HIV: not all respond to treatment

IAS: TMC114 plus low-dose ritonavir effective and well-tolerated in 3-class-experienced HIV patients

IAS: Routine thyroid testing advised for people taking antiretrovirals